New research suggests the HPV vaccine is preventing cancer in men, as well as in women. dpa/picture alliance via Getty Images These cancers are more than twice as common in men than in women.

The HPV vaccine demonstrates strong long-term protection against cervical cancer, yet the study underscores the necessity of ...

HPV vaccine prevents cancer in males as well as females, researchers say. Written by Robby Berman on June 3, 2024 — Fact checked by Jill Seladi-Schulman, Ph.D. ... Boston Globe/Getty Images.

Researchers have found a steep drop in deaths from cervical cancer, all thanks to the HPV (human papillomavirus) vaccine. American women aged under 25 between 2016 and 2021—who were the first ...

Despite evidence that the HPV vaccine is safe, effective and can help prevent cancer, HPV vaccination rates in the U.S. remain “suboptimal,” say experts.

The HPV vaccine, called Gardasil-9 — which has no live virus and is completely non-infectious — protects against the six types of HPV most likely to cause cancer, Eckert says. (These are ...

The HPV vaccine, called Gardasil-9 — which has no live virus and is completely non-infectious — protects against the six types of HPV most likely to cause cancer, Eckert says. (These are ...

For women, the vaccine primarily reduces the risk of cervical cancer, which is the most well-known and dangerous cancer linked to HPV. However, the protection it provides extends to other cancers ...

Just a single dose of vaccine against human papillomavirus may be enough to protect against HPV and cervical cancer, according to new research. The HPV vaccine is normally administered in two- or ...

New data show the vaccine reduced the risk of HPV-related cancers by 56% in men and 36% in women ... Vaccinated males had 3.4 cases of HPV-linked cancer per 100,000 patients compared to 7.5 ...

Now, if not for the slow adoption of the HPV vaccine by the parents of adolescents, we would likely be well on our way to eliminating nearly all cases of cervical cancer and the five other HPV ...

Women who were under 25 between 2016 and 2021 were among the first set of people to be offered the HPV vaccine, which prevents HPV infection and limits the virus's ability to cause cervical cancer.